Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ibuprofen, aspirin for platelet aggregation inhibition

This article was originally published in The Tan Sheet

Executive Summary

Taking 325 mg of aspirin followed by 400 mg of ibuprofen significantly reduces the magnitude and duration of inhibition of platelet aggregation, according to a study in the April Journal of Clinical Pharmacology. Researchers led by Francis M. Gengo, a pharmacy professor at State University of New York at Buffalo, conducted the study with 10 subjects taking either 325 mg of aspirin, 400 mg of aspirin or 400 mg of ibuprofen followed by 325 mg of aspirin two hours later. The researchers also conducted a confirmatory study for 27 months with 28 patients...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101482

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel